The global In Vitro Diagnostics market garnered revenue around USD 69,213 million in 2020 and projected to reach USD 93,190 million in 2027, with at a compound annual growth rate (CAGR) 5.7% throughout the estimate period from 2021 to 2027. In vitro diagnostics (IVD) are medical devices, which require use of assays and reagents to diagnose a medical condition. Moreover, these instruments analyze body fluids and tissue samples collected from a patient. In addition, there are various types of in vitro diagnostic instruments that work on different techniques such as immunodiagnostics, tissue diagnostics, hematology, and molecular diagnostics. Furthermore, in vitro diagnostics are employed in diagnosis of various medical conditions such as infectious diseases, cancer, cardiac disorders, and nephrological disorders. Moreover, use and handling of in vitro diagnostics require technical expertise and thus, instruments are used in specialized medical facilities to carry out diagnosis. For instance, IVD products are used in facilities such as standalone laboratories, hospitals, and point-of care.
This research report encompasses precise assessment of the market with the help of comprehensive qualitative insights and supportable prognoses regarding market size, consumption and production. The projections presented in the report have been derived using proven research methodologies and assumptions. It does so by means of comprehensive qualitative insights, historical statistics, and verifiable predictions about market revenue and sales.
The rapidly budding threat owed to the eruption of COVID-19 is impacting lives, communities, businesses, and industries across the globe. With businesses shuttered, flights grounded, COVID-19 is about to affect the global economy in different ways such as by directly upsetting production and demand, by generating supply chain disruption, and by its financial impact on firms and financial markets. Therefore, this report covers COVID-19 outbreak impact analysis on the In Vitro Diagnostics market under the research study. The market estimates offered in the report are the outcome of in-depth extensive secondary research, primary interviews and in-house professional assessments. These market evaluations have been measured by reviewing the impact of numerous social, political and economic factors coupled with recent market dynamics affecting the In Vitro Diagnostics market growth.
The global In Vitro Diagnostics market is characterized by the presence of numerous small as well as medium scale companies. These players are largely focused towards forward integration via raw material production, product manufacturing, and distribution across various industry verticals. The report recognizes numerous crucial manufacturers of the market. This research study aids to comprehend the strategies and associations that companies are converging to survive in this competitive marketplace. This report assists in understanding footprints of the manufacturers with the help of their global revenue, production, capacity and average selling price analysis for period 2016-2027.
Major manufacturers analysed under this study comprises:
The global in vitro diagnostics market is highly competitive and the prominent players in the market have adopted various strategies to garner maximum in vitro diagnostics market share. These include collaboration, product launch, partnership, and acquisition. Major players operating in the market include Abbott Laboratories, Becton, Dickinson and Company, bioMérieux SA, Bio-Rad Laboratories, Inc., Danaher Corporation (Beckman Coulter, Inc.), F. Hoffmann-La Roche AG, Siemens AG, QIAGEN N.V., Sysmex Corporation, and Thermo Fisher Scientific, Inc.
This report delivers market breakdown and its revenue, consumption, production analysis and projections by categorizing it depending on parameters such as type, application/end-user, and region. This research report delivers the analysis and prognosis of revenue, production, price, market share and growth trend for different products such as:
By Product & Service
· Reagents
· Instruments
· Software and Services
By Technique
· Immunodiagnostics
o Enzyme-Linked Immunosorbent Assay (ELISA)
§ Chemiluminescence Immunoassay (CLIA)
§ Fluorescence immunoassay (FIA)
§ Colorimetric Immunoassay (CI)
· Tissue Diagnostics
· Clinical Chemistry
o Basic Metabolic Panel
o Liver Panel
o Lipid Profile
o Thyroid Function Panel
o Electrolyte Panel
o Specialty Chemicals
· Others
By Application
· Infectious Diseases
· Cancer
· Cardiac Diseases
· Immune System Disorders
· Nephrological Diseases
· Gastrointestinal Diseases
· Others
By End User
· Standalone Laboratories
· Hospitals
· Academic & Medical Schools
· Point-of-Care
· Others
Regional Analysis and Forecast
Further, this research study analyses market size, production, consumption and its advancement trends at global, regional, and country level for period 2016 to 2027 and covers following region in its scope:
North America
United States
Canada
Europe
Germany
United Kingdom
Italy
France
Rest of EU
Asia Pacific
China
India
Japan
Southeast Asia
Rest of APAC
Central & South America
Brazil
Argentina
Rest of Central & South America
Middle East and Africa
GCC
North Africa
South Africa
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global In Vitro Diagnostics Market, By Product & Service
7.1. In Vitro Diagnostics Market, by Product & Service, 2020-2027
7.1.1. Reagents
7.1.1.1. Market Revenue and Forecast (2016-2027)
7.1.2. Instruments
7.1.2.1. Market Revenue and Forecast (2016-2027)
7.1.3. Software and Services
7.1.3.1. Market Revenue and Forecast (2016-2027)
Chapter 8. Global In Vitro Diagnostics Market, By Technique
8.1. In Vitro Diagnostics Market, by Technique, 2020-2027
8.1.1. Immunodiagnostics
8.1.1.1. Market Revenue and Forecast (2016-2027)
8.1.2. Hematology
8.1.2.1. Market Revenue and Forecast (2016-2027)
8.1.3. Molecular Diagnostics
8.1.3.1. Market Revenue and Forecast (2016-2027)
8.1.4. Tissue Diagnostics
8.1.4.1. Market Revenue and Forecast (2016-2027)
8.1.5. Clinical Chemistry
8.1.5.1. Market Revenue and Forecast (2016-2027)
8.1.6. Others
8.1.6.1. Market Revenue and Forecast (2016-2027)
Chapter 9. Global In Vitro Diagnostics Market, By Application
9.1. In Vitro Diagnostics Market, by Application, 2020-2027
9.1.1. Infectious Diseases
9.1.1.1. Market Revenue and Forecast (2016-2027)
9.1.2. Cancer
9.1.2.1. Market Revenue and Forecast (2016-2027)
9.1.3. Cardiac Diseases
9.1.3.1. Market Revenue and Forecast (2016-2027)
9.1.4. Immune System Disorders
9.1.4.1. Market Revenue and Forecast (2016-2027)
9.1.5. Nephrological Diseases
9.1.5.1. Market Revenue and Forecast (2016-2027)
9.1.6. Gastrointestinal Diseases
9.1.6.1. Market Revenue and Forecast (2016-2027)
9.1.7. Others
9.1.7.1. Market Revenue and Forecast (2016-2027)
Chapter 10. Global In Vitro Diagnostics Market, By End User
10.1. In Vitro Diagnostics Market, by End User, 2020-2027
10.1.1. Standalone Laboratories
10.1.1.1. Market Revenue and Forecast (2016-2027)
10.1.2. Hospitals
10.1.2.1. Market Revenue and Forecast (2016-2027)
10.1.3. Academic & Medical Schools
10.1.3.1. Market Revenue and Forecast (2016-2027)
10.1.4. Point-of-Care
10.1.4.1. Market Revenue and Forecast (2016-2027)
10.1.5. Others
10.1.5.1. Market Revenue and Forecast (2016-2027)
Chapter 11. Global In Vitro Diagnostics Market, Regional Estimates and Trend Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, by Product & Service (2016-2027)
11.1.2. Market Revenue and Forecast, by Technique (2016-2027)
11.1.3. Market Revenue and Forecast, by Application (2016-2027)
11.1.4. Market Revenue and Forecast, by End User (2016-2027)
11.1.5. U.S.
11.1.5.1. Market Revenue and Forecast, by Product & Service (2016-2027)
11.1.5.2. Market Revenue and Forecast, by Technique (2016-2027)
11.1.5.3. Market Revenue and Forecast, by Application (2016-2027)
11.1.5.4. Market Revenue and Forecast, by End User (2016-2027)
11.1.6. Rest of North America
11.1.6.1. Market Revenue and Forecast, by Product & Service (2016-2027)
11.1.6.2. Market Revenue and Forecast, by Technique (2016-2027)
11.1.6.3. Market Revenue and Forecast, by Application (2016-2027)
11.1.6.4. Market Revenue and Forecast, by End User (2016-2027)
11.2. Europe
11.2.1. Market Revenue and Forecast, by Product & Service (2016-2027)
11.2.2. Market Revenue and Forecast, by Technique (2016-2027)
11.2.3. Market Revenue and Forecast, by Application (2016-2027)
11.2.4. Market Revenue and Forecast, by End User (2016-2027)
11.2.5. UK
11.2.5.1. Market Revenue and Forecast, by Product & Service (2016-2027)
11.2.5.2. Market Revenue and Forecast, by Technique (2016-2027)
11.2.5.3. Market Revenue and Forecast, by Application (2016-2027)
11.2.5.4. Market Revenue and Forecast, by End User (2016-2027)
11.2.6. Germany
11.2.6.1. Market Revenue and Forecast, by Product & Service(2016-2027)
11.2.6.2. Market Revenue and Forecast, by Technique (2016-2027)
11.2.6.3. Market Revenue and Forecast, by Application (2016-2027)
11.2.6.4. Market Revenue and Forecast, by End User (2016-2027)
11.2.7. France
11.2.7.1. Market Revenue and Forecast, by Product & Service (2016-2027)
11.2.7.2. Market Revenue and Forecast, by Technique (2016-2027)
11.2.7.3. Market Revenue and Forecast, by Application (2016-2027)
11.2.7.4. Market Revenue and Forecast, by End User (2016-2027)
11.2.8. Rest of Europe
11.2.8.1. Market Revenue and Forecast, by Product & Service (2016-2027)
11.2.8.2. Market Revenue and Forecast, by Technique (2016-2027)
11.2.8.3. Market Revenue and Forecast, by Application (2016-2027)
11.2.8.4. Market Revenue and Forecast, by End User (2016-2027)
11.3. APAC
11.3.1. Market Revenue and Forecast, by Product & Service (2016-2027)
11.3.2. Market Revenue and Forecast, by Technique (2016-2027)
11.3.3. Market Revenue and Forecast, by Application (2016-2027)
11.3.4. Market Revenue and Forecast, by End User (2016-2027)
11.3.5. India
11.3.5.1. Market Revenue and Forecast, by Product & Service (2016-2027)
11.3.5.2. Market Revenue and Forecast, by Technique (2016-2027)
11.3.5.3. Market Revenue and Forecast, by Application (2016-2027)
11.3.5.4. Market Revenue and Forecast, by End User (2016-2027)
11.3.6. China
11.3.6.1. Market Revenue and Forecast, by Product & Service (2016-2027)
11.3.6.2. Market Revenue and Forecast, by Technique (2016-2027)
11.3.6.3. Market Revenue and Forecast, by Application (2016-2027)
11.3.6.4. Market Revenue and Forecast, by End User (2016-2027)
11.3.7. Japan
11.3.7.1. Market Revenue and Forecast, by Product & Service (2016-2027)
11.3.7.2. Market Revenue and Forecast, by Technique (2016-2027)
11.3.7.3. Market Revenue and Forecast, by Application (2016-2027)
11.3.7.4. Market Revenue and Forecast, by End User (2016-2027)
11.3.8. Rest of APAC
11.3.8.1. Market Revenue and Forecast, by Product & Service (2016-2027)
11.3.8.2. Market Revenue and Forecast, by Technique (2016-2027)
11.3.8.3. Market Revenue and Forecast, by Application (2016-2027)
11.3.8.4. Market Revenue and Forecast, by End User (2016-2027)
11.4. MEA
11.4.1. Market Revenue and Forecast, by Product & Service (2016-2027)
11.4.2. Market Revenue and Forecast, by Technique (2016-2027)
11.4.3. Market Revenue and Forecast, by Application (2016-2027)
11.4.4. Market Revenue and Forecast, by End User (2016-2027)
11.4.5. GCC
11.4.5.1. Market Revenue and Forecast, by Product & Service (2016-2027)
11.4.5.2. Market Revenue and Forecast, by Technique (2016-2027)
11.4.5.3. Market Revenue and Forecast, by Application (2016-2027)
11.4.5.4. Market Revenue and Forecast, by End User (2016-2027)
11.4.6. North Africa
11.4.6.1. Market Revenue and Forecast, by Product & Service (2016-2027)
11.4.6.2. Market Revenue and Forecast, by Technique (2016-2027)
11.4.6.3. Market Revenue and Forecast, by Application (2016-2027)
11.4.6.4. Market Revenue and Forecast, by End User (2016-2027)
11.4.7. South Africa
11.4.7.1. Market Revenue and Forecast, by Product & Service (2016-2027)
11.4.7.2. Market Revenue and Forecast, by Technique (2016-2027)
11.4.7.3. Market Revenue and Forecast, by Application (2016-2027)
11.4.7.4. Market Revenue and Forecast, by End User (2016-2027)
11.4.8. Rest of MEA
11.4.8.1. Market Revenue and Forecast, by Product & Service (2016-2027)
11.4.8.2. Market Revenue and Forecast, by Technique (2016-2027)
11.4.8.3. Market Revenue and Forecast, by Application (2016-2027)
11.4.8.4. Market Revenue and Forecast, by End User (2016-2027)
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Product & Service (2016-2027)
11.5.2. Market Revenue and Forecast, by Technique (2016-2027)
11.5.3. Market Revenue and Forecast, by Application (2016-2027)
11.5.4. Market Revenue and Forecast, by End User (2016-2027)
11.5.5. Brazil
11.5.5.1. Market Revenue and Forecast, by Product & Service (2016-2027)
11.5.5.2. Market Revenue and Forecast, by Technique (2016-2027)
11.5.5.3. Market Revenue and Forecast, by Application (2016-2027)
11.5.5.4. Market Revenue and Forecast, by End User (2016-2027)
11.5.6. Rest of LATAM
11.5.6.1. Market Revenue and Forecast, by Product & Service (2016-2027)
11.5.6.2. Market Revenue and Forecast, by Technique (2016-2027)
11.5.6.3. Market Revenue and Forecast, by Application (2016-2027)
11.5.6.4. Market Revenue and Forecast, by End User (2016-2027)
Chapter 12. Company Profiles
12.1. Abbott Laboratories
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Becton
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Dickinson and Company
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. bioMérieux SA
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Bio-Rad Laboratories, Inc.
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Danaher Corporation (Beckman Coulter, Inc.)
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. F. Hoffmann-La Roche AG
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Siemens AG
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. QIAGEN N.V.
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. Sysmex Corporation
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
12.11. Thermo Fisher Scientific, Inc.
12.11.1. Company Overview
12.11.2. Product Offerings
12.11.3. Financial Performance
12.11.4. Recent Initiatives
Chapter 13. Research Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
14.2. Glossary of Terms